Atlas Trials

Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT07690891 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07690891
Sponsor
Medical College of Wisconsin
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2026-10-01
Primary completion
2029-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.